- The trend backdrop is active with a 5-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
AKZA
AMS
Week ended 07 Aug 2026
Weekly Investor Report
Akzo Nobel N.V. · Basic Materials · Specialty Chemicals
Latest close
63.70 EUR
4.8%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 15.1% above the Trend Line and sits at 82.7% of its 52-week range. The latest completed week returned 4.8%, after a 11.0% four-week move. The latest news-sentiment score is 57/100.
Setup score
54
out of 100
Latest Close
63.70 EUR
7 Aug 2026
1W Return
4.8%
latest completed week
4W Return
11.0%
short-term follow-through
12W Return
30.0%
quarterly tape
Trend Breadth
38.5%
20 of 52 weeks active
Volume Ratio
1.0x
vs 13-week average
- Next-week expectancy is negative at 44.69% based on similar historical setup states.
- Recent volatility is running well above the one-year baseline.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
4.8%
Latest completed week; four-week move 11.0%.
Indicator stack
38/64
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 44.69%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
57/100
18 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 15.1% above the Trend Line and sits at 82.7% of its 52-week range. The latest completed week returned 4.8%, after a 11.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.6612-week average 0.36
12-week confirmation
Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership2/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.66Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 11.0% over four weeks, 30.0% over 12 weeks, and 18.1% over one year. The current trend has remained active for 5 consecutive weeks.
Performance by holding period
Active trend streak5 weeks
Active weeks in one year20
Trend breadth38.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.73Latest activity-pressure read.
Pressure change7.2%Four-week change in activity pressure.
Leadership1.40Latest relative-leadership reading.
RS change119.6%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment57/100
Weighted news tone is neutral across 18 relevant articles.
2 positive · 16 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-5.8%Distance below the 52-week high.
13-week volatility8.5%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher15 of 2611 weeks finished lower.
Best week+26.6%Week of 29 May.
Worst week-12.7%Week of 5 Jun.
Latest week+4.8%Week of 7 Aug.
Shape of recent returns
Strong gains6
Modest gains9
Flat weeks0
Modest losses7
Sharp losses4
Recent vol8.5%13-week weekly-return volatility.
Base vol5.4%52-week weekly-return volatility.
Up/down split30/22Count of positive and negative weeks in the 52-week window.
Average skew3.2% / -3.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorNL Basic Materials
4-week rank3 / 12
Group average3.9%
Trend breadth66.7%
Trend66.7%active weekly trend signals
MD41.7%positive activity pressure
RS50.0%positive relative leadership
Four-week leaders
IndustryNL Specialty Chemicals
4-week rank3 / 7
Group average5.3%
Trend breadth71.4%
Trend71.4%active weekly trend signals
MD57.1%positive activity pressure
RS42.9%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape47/100
Trend, activity pressure, participation, and risk combine to a 47/100 tape read.
Indicator analysis52/100Latest 12-week confirmation: trend 5/12, activity pressure 10/12, relative leadership 2/12.
Activity pressure 0.66; No reversal markers Next-Week ExpectancyNegative 44.69%Next-week expectancy is negative with a 44.69% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment57/100Weighted news tone is neutral across 18 relevant articles.
Akzo Nobel: Axalta Merger Beats Nippon's Bid (OTCMKTS:AKZOF) Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 63.70 EUR | 4.8% | 55.37 EUR | 57.08 EUR | 0.73 | 1.40 | 2.2M | On |
| 31 Jul 2026 | 60.78 EUR | 5.0% | 55.16 EUR | 57.10 EUR | 0.64 | -2.27 | 2.6M | On |
| 24 Jul 2026 | 57.86 EUR | 0.5% | 55.06 EUR | 57.16 EUR | 0.62 | -6.30 | 2.5M | On |
| 17 Jul 2026 | 57.58 EUR | 0.3% | 55.03 EUR | 57.24 EUR | 0.68 | -7.20 | 3.3M | On |
| 10 Jul 2026 | 57.40 EUR | -5.6% | 54.99 EUR | 57.30 EUR | 0.68 | -7.14 | 2.1M | On |
| 3 Jul 2026 | 60.80 EUR | 0.8% | 54.91 EUR | 57.35 EUR | 0.69 | -1.89 | 218.2K | Off |
| 26 Jun 2026 | 60.34 EUR | 3.0% | 54.68 EUR | 57.38 EUR | 0.66 | -0.81 | 475.1K | Off |
| 19 Jun 2026 | 58.58 EUR | 1.4% | 54.48 EUR | 57.43 EUR | 0.82 | -5.45 | 1.0M | Off |
| 12 Jun 2026 | 57.78 EUR | 0.8% | 54.27 EUR | 57.46 EUR | 0.55 | -7.21 | 858.3K | Off |
| 5 Jun 2026 | 57.32 EUR | -12.7% | 54.21 EUR | 57.50 EUR | 0.19 | -4.64 | 1.3M | Off |
| 29 May 2026 | 65.66 EUR | 26.6% | 54.16 EUR | 57.54 EUR | -0.10 | 9.70 | 8.6M | Off |
| 22 May 2026 | 51.88 EUR | 5.9% | 53.83 EUR | 57.54 EUR | -0.67 | -14.14 | 2.1M | Off |
| 15 May 2026 | 49.00 EUR | -3.4% | 54.05 EUR | 57.63 EUR | -0.72 | -16.49 | 1.8M | Off |
| 8 May 2026 | 50.74 EUR | 1.7% | 54.38 EUR | 57.76 EUR | -0.55 | -14.50 | 2.9M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.